More News – Page 113
-
News€20 million EIB venture debt financing to support microbiome research and development
The EIB has signed €20 million in venture debt financing with Belgian microbiome health company The Akkermansia Company to accelerate the R&D and commercial activities around the Akkermansia muciniphila bacterium.
-
NewsMpox vaccine triggers equally strong immune response in smaller doses
Delivering the two-dose mpox vaccine in smaller than the usual FDA-approved doses produced a detectable immune response. This also occurred regardless of whether people were living with or without HIV.
-
News Researchers develop a novel dry-powder inhaled vaccine platform
Researchers have developed a single-dose, dry-powder, inhalable vaccine platform using nano-micro composite multilevel structures, which is effective in blocking respiratory viral infection and transmission in animal models.
-
NewsCall for papers for themed Pseudomonas collection in Letters in Applied Microbiology
The journal Letters in Applied Microbiology is to run a themed collection on ’Emerging Horizons in Pseudomonas Biotechnology – Innovations from Early-Career Researchers’.
-
News‘Long flu’ has emerged as a consequence similar to long COVID
A new study shows patients hospitalized for flu or COVID-19 face an increased risk of long-term health problems and death.
-
NewsNovel early-detection method aims to stem disease spread in animal trade
Researchers have described a simplified method to detect a deadly fungus killing European salamanders - Batrachochytrium salamandrivorans, or Bsal.
-
NewsBlack individuals more likely to experience inequities in early diagnosis of Lyme disease
A new study reveals that black patients are more likely to have advanced stages of Lyme disease when clinically diagnosed and also experience a longer time before receiving antibiotic treatment for the condition.
-
NewsLong term green manuring strengthens core microbiomes
Scientists have presented evidence of the unique role of green manure in keeping and improving soil health, specifically hairy vetch, which is widely used in seasonal or spatial fallow farmland in northern China.
-
NewsSilent carriers: long-standing SARS-CoV-2 RNA in respiratory vesicles
Studies exploring extracellular vesicles (EVs) have uncovered an important piece of information: SARS-CoV-2 RNA was present in EVs in individuals who tested negative via standard RT-PCR methods.
-
NewsResearchers develop potential vaccine against antibiotic-resistant enterococci
Researchers have discovered how to create an enterococcal vaccine that is relatively easy to produce and takes advantage of membrane vesicles.
-
NewsFAU to create South Florida’s first microbiome innovation center
Florida Atlantic University, in collaboration with Florida International University, has received a four-year USDA $1 million grant to establish South Florida’s first-of-its-kind FAU Microbiome Innovation Center.
-
NewsCOVID-19 vaccine candidates show robust boosting potential
Two COVID-19 vaccines have shown strong potential to be an improved approach for boosting immunity to SARS-CoV-2 variants according to interim results of a Phase 1 clinical trial.
-
NewsPatients can pause immune-suppressing medicines for COVID-19 booster vaccine
A major clinical trial shows that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.
-
NewsMade-to-order diagnostic tests may be on the horizon
Researchers have made a breakthrough in diagnostic technology, inventing a ‘lab on a chip’ that can be 3D-printed in just 30 minutes. The chip has the potential to make on-the-spot testing widely accessible.
-
NewsAdvanced MRI technology detects changes in the brain after COVID-19
Researchers have found differences in brain tissue structure between patients with persisting symptoms after COVID-19 and healthy people.
-
NewsNovel compounds promise success in the fight against tuberculosis and depression
Scientists have shown that a specific polyprenylated polycyclic acylphloroglucinol, PPAP53, is able to activate human macrophages to fight resistant tuberculosis bacteria without being toxic to the macrophages themselves.
-
NewsScientists reveal ‘burrowing effect’ of foraminifera on marine environments
Scientists have shown for the first time that the burrowing of single-celled organisms in marine ecosystems affects oxygen distribution and bacterial diversity in sea sediments.
-
NewsExogenous arginine promotes coproduction of biomass and astaxanthin in algae
Scientists have discovered that arginine supplements can enhance the growth and astaxanthin production of Haematococcus pluvialis.
-
NewsBathyarchaeia encode novel methyltransferase utilizing lignin-derived aromatics
Researchers have presented a successful continuous enrichment of Bathyarchaeia along with the discovery of a novel and specific methyltransferase for O-demethylation from lignin-derived aromatics.
-
NewsScientists find new, better way to develop vaccines
Researchers have developed a new system to display epitopes in mammal cells for immunization studies and believe that this method can help scientists greatly in immunization efforts.
